NovoCure NVCR Cash Flow Statement (2014-2026)

NASDAQ NVCR
$15.59 -0.12 (-0.76%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

NovoCure Quarterly Cash Flow Statement

Periods 48 quarters
Latest Jun 2026

NovoCure reported cash from operations of $8.13M and free cash flow of $1.22M for the quarter ended Jun 2026, up 151.0% year over year. This cash flow statement covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-13.12M-26.46M-4.65M-24.01M-26.58M-37.30M-53.06M-57.42M-49.49M-47.08M-38.76M-33.38M-30.57M-65.92M-34.32M-40.14M-37.27M-24.50M-71.14M-15.66M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.79M0.79M0.68M0.83M0.23M-3.28M-4.06M-5.08M-6.69M-7.26M-5.38M-6.85M-6.74M-6.67M-6.65M-6.46M-6.40M-3.75M-2.62M-2.59M
Depreciation & Amortization (CF)Dep. & Amort.
2.73M2.67M2.61M2.65M2.66M2.70M2.72M2.72M2.80M2.72M2.82M2.86M2.46M3.10M3.33M3.44M3.66M4.22M4.12M4.31M
Share-based CompensationStock Comp.
25.76M22.40M25.05M25.82M26.31M29.78M39.08M32.74M26.35M17.44M34.08M31.83M31.36M62.76M29.55M26.14M29.32M19.82M63.01M17.01M
Asset Writedowns and ImpairmentWritedown
0.11M0.18M0.14M0.22M0.16M0.44M0.13M0.14M0.11M0.12M0.19M0.14M0.45M0.38M2.26M0.42M0.23M1.94M0.71M0.74M
Other non-cash itemsOther Non-Cash
0.50M0.21M0.25M0.94M-0.14M-4.31M-0.13M0.91M1.40M-2.02M0.61M0.65M-0.50M-0.99M-0.05M1.37M0.89M-0.96M0.48M0.02M
Change in Working Capital
Change in ReceivablesChange Receivables
3.73M-1.35M7.46M-2.26M-11.52M3.77M-14.51M-6.94M-2.64M
Change in InventoryChange Inventory
-3.82M1.70M4.80M0.21M-2.95M2.28M2.72M1.45M4.08M0.67M4.65M-1.89M-1.90M-3.44M3.94M0.63M-0.89M1.98M2.78M-0.87M
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
8.13M17.16M-14.81M7.65M5.27M16.15M-10.46M1.17M6.27M18.86M-18.25M9.55M7.45M20.35M-16.42M5.92M24.83M8.44M-5.12M2.80M
Change in Other Operating AssetsOther Assets Change
-1.37M-0.14M-1.86M-2.36M-1.67M-1.22M-1.53M1.92M-3.97M-0.49M-1.17M-4.89M-1.91M0.57M-2.58M-1.41M-2.49M-4.37M-2.04M-2.91M
Change in Other Operating LiabilitiesOther Liabilities Change
-1.95M-2.22M-2.33M-2.14M-1.63M-1.67M-3.16M-1.70M-3.08M-1.85M-1.77M-1.83M-1.54M-1.23M-1.12M0.92M-2.43M-2.64M-2.84M-2.79M
Other Working Capital ChangesOther WC Changes
-0.58M-2.09M-0.47M0.21M0.04M-0.45M-1.62M-3.62M0.90M-1.36M-0.59M3.06M0.37M-1.80M1.46M2.33M0.06M1.72M-0.80M0.12M
Cash from OperationsCash from Ops.
24.40M14.40M-3.69M15.76M22.42M-3.71M-16.73M-22.74M-19.31M-14.56M-31.57M-1.72M10.38M-3.45M-35.67M-15.94M20.57M-18.00M-13.52M8.13M
Investing Activities
Capital ExpendituresCapex
3.30M14.27M5.09M4.13M5.70M6.43M6.09M6.93M7.25M6.82M11.78M11.45M10.68M8.94M10.61M5.49M5.66M4.90M5.15M6.92M
Change in Property, Plant and EquipmentChange in PP&E
-3.30M-14.27M-5.09M-4.13M-5.70M-6.43M-6.09M-6.93M-7.25M-6.82M-11.78M-11.45M-10.68M-8.94M-10.61M-5.49M-5.66M-4.90M-5.15M-6.92M
Purchase of InvestmentsInvestments Purchased
44.00M484.82M291.32M277.15M503.27M226.16M237.91M321.56M251.04M193.23M522.99M169.12M183.27M115.86M378.53M107.91M218.78M97.10M94.46M
Sale and Maturity of InvestmentsInvestments Sold
350.00M279.00M437.03M358.73M104.53M326.29M314.60M275.55M298.55M258.00M160.00M190.00M170.00M120.00M420.00M185.00M560.00M110.00M95.00M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
302.70M-499.09M-17.41M155.76M-150.24M-128.06M82.29M-13.90M17.26M98.50M246.22M-374.44M10.19M-22.21M-6.47M35.99M71.44M336.33M7.75M-6.38M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
96.92M99.98M
Long-Term Debt RepaymentsLT Debt Repayment
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M12.91M560.95M
Non-Current Debt
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M96.92M-12.91M99.98M-560.95M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M0.00M96.92M-12.91M99.98M-560.95M
Change in Capital Stock
Common Stock IssuedStock Issued
3.04M3.66M3.15M4.74M4.21M3.42M5.21M7.51M1.17M1.91M0.21M3.31M0.10M2.69M5.25M2.39M0.54M1.60M0.39M4.55M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
3.04M3.66M3.15M4.74M4.21M3.42M5.21M7.51M1.17M1.91M0.21M3.31M0.10M2.69M5.25M2.39M0.54M1.60M0.39M4.55M
Net Equity Issued and RepurchasedNet Equity Issued
3.04M3.66M3.15M4.74M4.21M3.42M5.21M7.51M1.17M1.91M0.21M3.31M0.10M2.69M5.25M2.39M0.54M1.60M0.39M4.55M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
3.04M3.65M3.14M4.74M4.20M3.41M5.20M7.50M1.17M1.91M0.21M87.32M0.10M2.69M5.25M2.39M100.52M-559.49M-0.17M4.55M
Additional items
Exchange Rate EffectFX Effect
-0.03M-0.05M-0.03M-0.12M-0.11M0.16M0.04M-0.01M-0.10M0.20M-0.06M-0.08M0.09M-0.13M0.23M0.27M-0.02M-0.08M-0.13M-0.01M
Change in Cash
330.11M-481.08M-17.98M176.14M-123.73M-128.20M70.81M-29.15M-0.98M86.05M214.80M-288.92M20.76M-23.11M-36.66M22.70M192.51M-241.25M-6.07M6.29M
Ending Cash Balance
690.69M209.61M191.63M367.76M244.04M115.83M186.64M157.49M156.51M242.56M457.36M168.44M189.20M166.09M129.43M152.13M344.64M103.39M97.32M103.62M
Free Cash FlowFCF
21.10M0.13M-8.78M11.63M16.72M-10.14M-22.82M-29.67M-26.57M-21.38M-43.36M-13.17M-0.31M-12.39M-46.28M-21.42M14.92M-22.90M-18.67M1.22M
Net Cash FlowNCF
330.14M-481.03M-17.96M176.26M-123.62M-128.36M70.76M-29.13M-0.89M85.85M214.86M-288.84M20.67M-22.98M-36.89M22.44M192.53M-241.17M-5.94M6.30M
Interest Paid
0.00M0.10M0.00M0.00M0.00M0.04M0.00M0.01M0.00M1.97M2.96M2.78M2.65M2.67M2.84M5.24M4.96M5.03M
Income Taxes PaidTaxes Paid
0.99M2.04M1.17M1.85M0.91M1.55M1.71M5.83M1.20M4.92M2.91M7.50M6.64M6.41M4.97M13.84M3.43M8.43M-3.88M2.87M

NovoCure Cash Flow Statement API

Pull NovoCure's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVCR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY